UK referendum on Europe: what’s the potential medtech regulatory fallout?
This article was originally published in Clinica
Executive Summary
For the last two and a half decades, the careers of EU medtech regulatory experts have orbited around the output of Brussels and its impact at EU, national and even international level. So should those of us in the UK fear the referendum on EU membership, as promised by the newly elected Conservative government? How worried should the UK be – and indeed the rest of Europe – in terms of regulatory stability should the outcome of the vote, expected in 2017, signal an exit from the EU? And what will the impact be on the rest of Europe?